Multiple Myeloma (MM) Completed Phase 1 Trials for Retaspimycin (DB05626)

Also known as: MULTIPLE MYELOMA (MM) / Multiple myeloma / Myeloma, Multiple / Multiple Myelomas / Multiple Myeloma(MM) / Plasma cell myelomas / Myelomatosis multiple / Peripheral plasma cell myeloma / Myelomatosis / Multiple myeloma myelomatosis / Plasma cell myeloma / Myeloma / Multiple myeloma with failed remission

IndicationStatusPhase
DBCOND0040908 (Multiple Myeloma (MM))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00113204Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple MyelomaTreatment